Inventor · disambiguated record
Yun Li
Also filed as: LI YUN · LI YUN ROSE · LI YUN S
13 granted patents·10 pending applications·95 citations·filing 2001–2025
90Inventor score
Files withHEALTH RESEARCH INC8UNIV DUKE4CHILDRENS HOSPITAL PHILADELPHIA3FUTUREGEN BIOPHARMACEUTICAL BEIJING CO LTD3CHEN XIAOZHUO1
Top patents by PatentIndex Score
23 records- 0195US9611308B2Compositions and methods for enhancing odorant receptor activityUNIV DUKE·Filed 2015·Granted Apr 4, 2017·15 cites·1 claims
- 0290US10385398B2Methods for use in combination for the treatment and diagnosis of autoimmune diseasesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2016·Granted Aug 20, 2019·12 cites·13 claims
- 0390US9068226B2Compositions and methods for enhancing odorant receptor activityMATSUNAMI HIROAKI·Filed 2010·Granted Jun 30, 2015·12 cites·2 claims
- 0487US6812248B2Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymesUNIV JOHNS HOPKINS·Filed 2001·Granted Nov 2, 2004·35 cites·6 claims
- 0585US10407725B2Methods of treating autoimmune conditions in patients with genetic variations in DcR3 or in a DcR3 network geneCHILDRENS HOSPITAL PHILADELPHIA·Filed 2016·Granted Sep 10, 2019·7 cites·16 claims
- 0685US9486434B2Method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancerZHANG YUESHENG·Filed 2012·Granted Nov 8, 2016·12 cites·6 claims
- 0781US2024293518A1METHOD FOR PROPHYLAXIS AND/OR TREATMENT OF ErbB2 POSITIVE CANCERSHEALTH RESEARCH INC·Filed 2024·Application pending·0 cites
- 0876US11136548B2Culture medium for generating microglia from pluripotent stem cells and related methodsWHITEHEAD INST BIOMEDICAL RES·Filed 2016·Granted Oct 5, 2021·2 cites·12 claims
- 0973US11718877B2Methods for use in the diagnosis of autoimmune diseasesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2019·Granted Aug 8, 2023·0 cites·8 claims
- 1073US10883143B2Compositions and methods for enhancing odorant receptor activityUNIV DUKE·Filed 2018·Granted Jan 5, 2021·0 cites·4 claims
- 1172US2021139986A1Compositions and methods for enhancing odorant receptor activityUNIV DUKE·Filed 2020·Application pending·0 cites
- 1271US11103563B2Method for prophylaxis and/or treatment of ErbB2 positive cancersHEALTH RESEARCH INC·Filed 2018·Granted Aug 31, 2021·0 cites·8 claims
- 1370US2021369820A1METHOD FOR PROPHYLAXIS AND/OR TREATMENT OF ErbB2 POSITIVE CANCERSHEALTH RESEARCH INC·Filed 2021·Application pending·0 cites
- 1468US10072292B2Compositions and methods for enhancing odorant receptor activityUNIV DUKE·Filed 2017·Granted Sep 11, 2018·0 cites·11 claims
- 1562US10155028B2Method for prophylaxis and/or treatment of ErbB2 positive cancersHEALTH RESEARCH INC·Filed 2014·Granted Dec 18, 2018·0 cites·6 claims
- 1662US2025009852A1Depleting egfr and her2 overcomes resistance to egfr inhibitors in colorectal cancerHEALTH RESEARCH INC·Filed 2022·Application pending·0 cites
- 1755US2025376533A1Anti-cd40 antibody, anti-pd-l1×cd40 bispecific antibody, and use thereofFUTUREGEN BIOPHARMACEUTICAL BEIJING CO LTD·Filed 2023·Application pending·0 cites
- 1851US10478477B2Method for prophylaxis or treatment of erbb1 positive cancers using a variant peptidase d with reduced activityHEALTH RESEARCH INC·Filed 2015·Granted Nov 19, 2019·0 cites·5 claims
- 1949US2022372490A1Reactivating p53 mutants for cancer treatment by targeting prolidase (pepd)HEALTH RESEARCH INC·Filed 2020·Application pending·0 cites
- 2045US2022235129A1Cldn18.2 antibody and use thereofFUTUREGEN BIOPHARMACEUTICAL BEIJING CO LTD·Filed 2020·Application pending·0 cites
- 2144US2006058243A1Methods and compositions for treating diabetes mellitisCHEN XIAOZHUO·Filed 2002·Application pending·0 cites
- 2242US2025313644A1Antibodies capable of specifically binding tl1a and use thereofFUTUREGEN BIOPHARMACEUTICAL BEIJING CO LTD·Filed 2025·Application pending·0 cites
- 2338US2018188270A1Diagnostic test for alzheimer's disease based on identification of a proteolytic pathwayHEALTH RESEARCH INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yun Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →